Jump to Content
1 page, collection control.
11/1/75 description of McNaughton Foundation.
4/14/69 correspondence Ronald L. Rakow to Chauncey D. Leake.
4/9/69 U. S. P. H. S. memo re: amygdalin.
Undated reprint from Minerva Chirurgica. Abstract of McNaughton paper "Hyperthermy of cancer cells with amygdalin-glucosidase ..."
Reprint from 7/21/75 Congressional Record: "Fluoridation and Cancer"
Preprint? of unidentified [1969?] article re: Diisopropylammonium dichloroacetate (DIPA).
McNaughton reprint of 1968 article "Vitamin B15 (Pangamic Acid). Indications for Use and Efficacy in Internal Disease."
McNaughton reprint of 1973 Physician's Handbook of Vitamin B-17 Therapy.
McNaughton reprint of 1975 A Brief on Foods and Vitamins.
The Laetriles - Nitrolisides - in the prevention and control of cancer (McNaughton reprint of seven pre-1964 articles, plus a bibliography)
3/14/69 McNaughton report to California State Department of Public Health. "Notice of claimed investigational exemption for a new drug. Laetrile (Amygdalin)."
same document, with 3/30/69 cover note to Ronald Rakow from Chauncey Leake.
4/6/70 McNaughton Foundation of California submission to FDA: "Laetrile - Amygdalin. Volume One."
4/6/70 McNaughton Foundation of California submission to FDA: "Laetrile - Amygdalin. Volume Two."
4/6/70 McNaughton Foundation of California submission to FDA: "Laetrile - Amygdalin. Volume Three."
4/6/70 McNaughton Foundation of California submission to FDA: "Laetrile - Amygdalin. Volume Four."
2/26/71 McNaughton Foundation of California response to FDA letter of 18 December 1970; packet includes other correspondence, reprints and data.
Physician's New Weapon, 1966 compilation of papers re: vitamin B15 (pangamic acid).
11/11/68 McNaughton Foundation Preclinical submission. Laetrile - Amygdalin.
7/10/69 typescript "Diisopropylammonium dichloroacetate (DIPA) and sodium dichloroacetate (DCA): effect on glucose and fat metabolism in normal and diatbetic tissue."